Impeding efflux-mediated resistance in Staphylococcus aureus

Staphylococcus aureus is one of the most common human pathogens that causes wide range of nosocomial and community acquired infections as wound and burn infections, food poisoning, endocarditis, pneumonia, meningitis and bacteremia. Beside its pathogenicity, it exhibits different antibiotic resistan...

Full description

Saved in:
Bibliographic Details
Published in:Research journal of pharmacy and technology 2022-09, p.4300-4308
Main Authors: Abdel-Karim, Safaa A. M., El-Ganiny, Amira M. A., El-Sayed, Mona A., A. Abbas, Hisham
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-crossref_primary_10_52711_0974_360X_2022_007223
container_end_page 4308
container_issue
container_start_page 4300
container_title Research journal of pharmacy and technology
container_volume
creator Abdel-Karim, Safaa A. M.
El-Ganiny, Amira M. A.
El-Sayed, Mona A.
A. Abbas, Hisham
description Staphylococcus aureus is one of the most common human pathogens that causes wide range of nosocomial and community acquired infections as wound and burn infections, food poisoning, endocarditis, pneumonia, meningitis and bacteremia. Beside its pathogenicity, it exhibits different antibiotic resistance mechanisms that complicate its treatment. Efflux is one of the resistance mechanisms that is used by bacterial pathogens to extrude antimicrobials as antibiotics and biocides and thus counteract their actions. Therefore, there is an urgent need for searching for compounds that have an efflux-inhibitory activity among the existing phar¬maceuticals and the compounds that are isolated from natural sources or the synthesis of novel derivatives to be able to treat S. aureus infections. Several efflux pump inhibitors have been identified or synthesized over the past years. In this review, we present the different compounds that have been proven to have an efflux-inhibitory activity against S. aureus and the current progress in their development.
doi_str_mv 10.52711/0974-360X.2022.00722
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_52711_0974_360X_2022_00722</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_52711_0974_360X_2022_00722</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_52711_0974_360X_2022_007223</originalsourceid><addsrcrecordid>eNqdzksKwjAQBuAgChbtEYRcoDVJn4I7UXStC3chpIlG-iLTgL29bREP4Gz-mYEfPoQ2lIQJyyjdkl0WB1FK7iEjjIWEZIzNkPd7z387zZfIB3iRYdI8YXHuof2lalVh6gdWWpfuHVTDJTpVYKvAQCdqqbCp8bUT7bMvG9lI6QALZ5WDNVpoUYLyv7lCyel4O5wDaRsAqzRvramE7TklfNLykcJHFh-1fNJG__Y-ZKpIyA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impeding efflux-mediated resistance in Staphylococcus aureus</title><source>Alma/SFX Local Collection</source><creator>Abdel-Karim, Safaa A. M. ; El-Ganiny, Amira M. A. ; El-Sayed, Mona A. ; A. Abbas, Hisham</creator><creatorcontrib>Abdel-Karim, Safaa A. M. ; El-Ganiny, Amira M. A. ; El-Sayed, Mona A. ; A. Abbas, Hisham</creatorcontrib><description>Staphylococcus aureus is one of the most common human pathogens that causes wide range of nosocomial and community acquired infections as wound and burn infections, food poisoning, endocarditis, pneumonia, meningitis and bacteremia. Beside its pathogenicity, it exhibits different antibiotic resistance mechanisms that complicate its treatment. Efflux is one of the resistance mechanisms that is used by bacterial pathogens to extrude antimicrobials as antibiotics and biocides and thus counteract their actions. Therefore, there is an urgent need for searching for compounds that have an efflux-inhibitory activity among the existing phar¬maceuticals and the compounds that are isolated from natural sources or the synthesis of novel derivatives to be able to treat S. aureus infections. Several efflux pump inhibitors have been identified or synthesized over the past years. In this review, we present the different compounds that have been proven to have an efflux-inhibitory activity against S. aureus and the current progress in their development.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>DOI: 10.52711/0974-360X.2022.00722</identifier><language>eng</language><ispartof>Research journal of pharmacy and technology, 2022-09, p.4300-4308</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-crossref_primary_10_52711_0974_360X_2022_007223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Abdel-Karim, Safaa A. M.</creatorcontrib><creatorcontrib>El-Ganiny, Amira M. A.</creatorcontrib><creatorcontrib>El-Sayed, Mona A.</creatorcontrib><creatorcontrib>A. Abbas, Hisham</creatorcontrib><title>Impeding efflux-mediated resistance in Staphylococcus aureus</title><title>Research journal of pharmacy and technology</title><description>Staphylococcus aureus is one of the most common human pathogens that causes wide range of nosocomial and community acquired infections as wound and burn infections, food poisoning, endocarditis, pneumonia, meningitis and bacteremia. Beside its pathogenicity, it exhibits different antibiotic resistance mechanisms that complicate its treatment. Efflux is one of the resistance mechanisms that is used by bacterial pathogens to extrude antimicrobials as antibiotics and biocides and thus counteract their actions. Therefore, there is an urgent need for searching for compounds that have an efflux-inhibitory activity among the existing phar¬maceuticals and the compounds that are isolated from natural sources or the synthesis of novel derivatives to be able to treat S. aureus infections. Several efflux pump inhibitors have been identified or synthesized over the past years. In this review, we present the different compounds that have been proven to have an efflux-inhibitory activity against S. aureus and the current progress in their development.</description><issn>0974-3618</issn><issn>0974-360X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqdzksKwjAQBuAgChbtEYRcoDVJn4I7UXStC3chpIlG-iLTgL29bREP4Gz-mYEfPoQ2lIQJyyjdkl0WB1FK7iEjjIWEZIzNkPd7z387zZfIB3iRYdI8YXHuof2lalVh6gdWWpfuHVTDJTpVYKvAQCdqqbCp8bUT7bMvG9lI6QALZ5WDNVpoUYLyv7lCyel4O5wDaRsAqzRvramE7TklfNLykcJHFh-1fNJG__Y-ZKpIyA</recordid><startdate>20220928</startdate><enddate>20220928</enddate><creator>Abdel-Karim, Safaa A. M.</creator><creator>El-Ganiny, Amira M. A.</creator><creator>El-Sayed, Mona A.</creator><creator>A. Abbas, Hisham</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220928</creationdate><title>Impeding efflux-mediated resistance in Staphylococcus aureus</title><author>Abdel-Karim, Safaa A. M. ; El-Ganiny, Amira M. A. ; El-Sayed, Mona A. ; A. Abbas, Hisham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_52711_0974_360X_2022_007223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Abdel-Karim, Safaa A. M.</creatorcontrib><creatorcontrib>El-Ganiny, Amira M. A.</creatorcontrib><creatorcontrib>El-Sayed, Mona A.</creatorcontrib><creatorcontrib>A. Abbas, Hisham</creatorcontrib><collection>CrossRef</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdel-Karim, Safaa A. M.</au><au>El-Ganiny, Amira M. A.</au><au>El-Sayed, Mona A.</au><au>A. Abbas, Hisham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impeding efflux-mediated resistance in Staphylococcus aureus</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2022-09-28</date><risdate>2022</risdate><spage>4300</spage><epage>4308</epage><pages>4300-4308</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><abstract>Staphylococcus aureus is one of the most common human pathogens that causes wide range of nosocomial and community acquired infections as wound and burn infections, food poisoning, endocarditis, pneumonia, meningitis and bacteremia. Beside its pathogenicity, it exhibits different antibiotic resistance mechanisms that complicate its treatment. Efflux is one of the resistance mechanisms that is used by bacterial pathogens to extrude antimicrobials as antibiotics and biocides and thus counteract their actions. Therefore, there is an urgent need for searching for compounds that have an efflux-inhibitory activity among the existing phar¬maceuticals and the compounds that are isolated from natural sources or the synthesis of novel derivatives to be able to treat S. aureus infections. Several efflux pump inhibitors have been identified or synthesized over the past years. In this review, we present the different compounds that have been proven to have an efflux-inhibitory activity against S. aureus and the current progress in their development.</abstract><doi>10.52711/0974-360X.2022.00722</doi></addata></record>
fulltext fulltext
identifier ISSN: 0974-3618
ispartof Research journal of pharmacy and technology, 2022-09, p.4300-4308
issn 0974-3618
0974-360X
language eng
recordid cdi_crossref_primary_10_52711_0974_360X_2022_00722
source Alma/SFX Local Collection
title Impeding efflux-mediated resistance in Staphylococcus aureus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A54%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impeding%20efflux-mediated%20resistance%20in%20Staphylococcus%20aureus&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Abdel-Karim,%20Safaa%20A.%20M.&rft.date=2022-09-28&rft.spage=4300&rft.epage=4308&rft.pages=4300-4308&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.52711/0974-360X.2022.00722&rft_dat=%3Ccrossref%3E10_52711_0974_360X_2022_00722%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_52711_0974_360X_2022_007223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true